Related Experiment Video
Updated: May 10, 2026
08:08
Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Pulmonary hypertension in chronic obstructive pulmonary disease
Emmanuel Weitzenblum1, Ari Chaouat, Romain Kessler
1Service de Pneumologie, Nouvel Hôpital Civil, 67091 Strasbourg Cedex, France. emmanuel.weitzenblum@chru-strasbourg.fr
Pneumonologia I Alergologia Polska
|June 8, 2013
Summary
Pulmonary hypertension (PH) is common in advanced chronic obstructive pulmonary disease (COPD). Long-term oxygen therapy is the primary treatment, potentially stabilizing PH progression.
Area of Science:
- Cardiology
- Pulmonology
- Respiratory Medicine
Background:
- Pulmonary hypertension (PH) frequently complicates advanced chronic obstructive pulmonary disease (COPD).
- COPD is the second leading cause of PH, primarily driven by chronic alveolar hypoxia and elevated pulmonary vascular resistance.
- PH in COPD typically ranges from mild to moderate, but severe cases carry a poor prognosis and can lead to right heart failure.
Purpose of the Study:
- To summarize the current understanding of pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD).
- To outline diagnostic approaches and treatment strategies for PH in COPD patients.
Main Methods:
- Review of existing literature on PH in COPD.
- Discussion of diagnostic tools including Doppler echocardiography and right heart catheterization.
- Analysis of current treatment modalities, focusing on long-term oxygen therapy.
Main Results:
- PH is a common complication of COPD, often mild to moderate but can be severe.
- Long-term oxygen therapy (≥16h/day) is the mainstay treatment, helping to stabilize or slow PH progression.
- Vasodilator use in COPD-associated PH is limited, with a need for further research.
Conclusions:
- PH significantly impacts COPD patients, particularly those with severe or disproportionate PH.
- Early diagnosis and management, including specialist referral and consideration for clinical trials, are crucial.
- Long-term oxygen therapy is effective, while the role of other treatments requires further investigation.
Related Concept Videos
01:30Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.